Joining us now is Democratic National Committee Chair Ken Martin to weigh in on this. >> Welcome, Chairman. Uh the congressman is not wrong.Um the speaker does have it within his power and capacity to to put together with the Republican caucus a bill um that would uh correspond to uh dealing with some of the issues related to Obamacare. Um the Democrats have been very very successful at leveling this up as uh both and this is important in my view both a national issue and a local issue. tying those two piec ...

A new class of drugs is saving the lives of children who once had no hope. These high-tech medicines can replace defective genes. But there's a catch. Many cost millions of dollars for a single dose. And American healthc care hasn't figured out how to pay. We wondered how medicine could be priced so high and how insurance plans could refuse a life-saving treatment. So, we asked the people you're about to meet, a drug maker whose company charges 3 million for its medication, a CEO whose insurance plan won't ...

Obamacare Criticism - President Trump advocates for direct payments to individuals instead of subsidies to profitable insurance companies [1] - Obamacare is deemed unaffordable and irreparable, with premiums significantly increasing [6][7] - The industry argues that Obamacare consolidated the market, reducing choices for consumers [21] Proposed Healthcare Alternatives - The proposal suggests giving subsidies directly to individuals, allowing them to choose plans that suit their needs and rewarding healthy behavior [8][11] - The industry emphasizes the need for competition and choice in the healthcare market to drive down costs [21] - The industry suggests allowing insurance companies to operate across state lines to increase competition [13] Political and Policy Considerations - Republicans aim to remove politics from healthcare policy and involve professionals to create an affordable, free-choice system [18] - Democrats are criticized for using healthcare as a leverage point and for supporting a system known to be flawed [16][14] - Concerns are raised about increasing the number of uninsured individuals if Obamacare is repealed without a viable replacement [20] Profitability of Insurance Companies - The industry questions the rationale behind subsidizing insurance companies that are already highly profitable [4][5] - Some insurance company stocks have seen substantial increases, such as rising from $30 to $330 per share [5] - The industry acknowledges that well-intentioned government regulations can dampen competition and increase healthcare inflation [12][13]

And joining us now is former Health and Human Services Secretary under President Obama, Kathleen Sibilius. She was one of the architects of Obamacare. Secretary Civilius, it's good to have you here.I want to highlight another family story. This one really, I think, has a huge impact. Helps paint the picture of the types of increases we're going to see.A family of four in Texas. They tell CNBC that they are currently paying $1,200 a month to ensure their family. But without the subsidies, their premiums are ...

RT Naval (@naval)Bitcoin is insurance against fiat.ZCash is insurance against Bitcoin. ...

Crypto Market Sentiment - Jim Cramer 表示加密货币“没问题”[1] - 个人将加密货币用作对冲风险的保险[1] Economic Context - 加密货币被用作对冲 37 万亿美元债务的保险[1]

RT EVject (@EVjectOfficial)Teslas are the safest vehicles ever made.So why are they more expensive to insure?EVject delivers options to charge safe and is now partnering with insurance companies to save you money. Better rates, discounted EVject devices?See if you're eligible, check link below. ...

Vaccine Recommendations & Insurance Coverage - Removing recommendations may impact patient choice, especially for vulnerable populations who rely on no-cost vaccines linked to CDC and ASIP recommendations [1][3] - Insurance companies have individual policies, some may not cover important treatments [2] - Various programs (private insurers, employer-sponsored plans, Medicare Part D, Medicaid, Vaccines for Children) link no-cost vaccines to CDC/ASIP recommendations [3] FDA's Role & Vaccine Safety - FDA's role is to assess the safety and effectiveness of submitted applications [4] - Concerns raised about potential loss of trust in the FDA due to policies perceived as "rubber stamping" vaccines without sufficient evidence, particularly for young, healthy individuals [5] - Industry emphasizes the need for strong evidence when recommending interventions, especially for new viruses and vaccines [5] - Clinical trial results in children were mixed four years ago [6]